1887

Access Microbiology open research platform logo

Volume 4, Issue 4

Case report and literature review: double jeopardy – and central line-associated bloodstream infection in a patient Open Access

Abstract

Central line-associated bloodstream infection (CLABSI) is the most common nosocomial-acquired infection, affecting 38 000 patients in the USA annually. Approximately 8–10 % of inserted catheters lead to bloodstream infections, and ~25–30 % of infections are associated with mortality. Although proper line maintenance is essential to prevent infection, it is quite a challenge to avoid infection in patients with a long-term catheter. We present a case of a female in her 40s with a previous history of irritable bowel syndrome (IBS) who has had a central line for total parenteral nutrition for the past 2 years. The patient recently visited the emergency room with fever and generalized fatigue. Blood cultures sent to microbiology were positive for black mould, . However, after a few days, microbiology reported an additional micro-organism, , a pathogen rarely associated with bacteraemia. The patient was administered voriconazole and moxifloxacin for black mould and mycobacterium infection, respectively. We present an unusual case of rare opportunistic organisms causing bacteraemia and fungaemia in a patient with a long-term catheter. CLABSI remains a serious challenge for clinical facilities. Implementation and monitoring of effective strategies can prevent catheter-related bloodstream infections in patients with long-term catheters and can reduce the morbidity and mortality associated with CLABSI.

  • Received:
  • Accepted:
  • Published Online:
Keyword(s): blood culture , catheter-associated infection (CLABSI) , Exophiala dermatitidis , irritable bowel syndrome , MALDI-TOF- MS and Mycobacterium canariasense
© 2022 The Authors
  • This is an open-access article distributed under the terms of the Creative Commons Attribution License. The Microbiology Society waived the open access fees for this article.
Loading

Article metrics loading...

/content/journal/acmi/10.1099/acmi.0.000347
2022-04-19
2024-04-19
Loading full text...

Full text loading...

/deliver/fulltext/acmi/4/4/acmi000347.html?itemId=/content/journal/acmi/10.1099/acmi.0.000347&mimeType=html&fmt=ahah

References

  1. CDC Central Line-associated Bloodstream Infection (CLABSI); 2021. [accessed January 2021] https://www.cdc.gov/hai/bsi/bsi.html
  2. Miller SE, Maragakis LL. Central line-associated bloodstream infection prevention. Curr Opin Infect Dis 2012; 25:412–422 [View Article] [PubMed]
     [Google Scholar]
  3. Wise ME, Scott RD 2nd, Baggs JM, Edwards JR, Ellingson KD et al. National estimates of central line-associated bloodstream infections in critical care patients. Infect Control Hosp Epidemiol 2013; 34:547–554 [View Article] [PubMed]
     [Google Scholar]
  4. McMullen KM, Smith BA, Rebmann T. Impact of SARS-CoV-2 on hospital acquired infection rates in the United States: Predictions and early results. Am J Infect Control 2020; 48:1409–1411 [View Article] [PubMed]
     [Google Scholar]
  5. CDC Prevention of Central Line-associated Bloodstream Infection (CLABSI); 2022. [accessed May 2021] https://www.cdc.gov/hai/bsi/bsi.html
  6. National Centre for Emerging and Zoonotic Infectious Diseases NHSN Laboratory Confirmed Bloodstream Infection (LCBI) Checklist. CDC; 2021
  7. National Healthcare Safety Network National Healthcare Safety Network (NHSN) Surveillance Definitions: Central Line Associated Bloodstream Infection (CLABSI) & Related Sites. CDC; 2022 https://www.cdc.gov/nhsn/pdfs/pscmanual/4psc_clabscurrent.pdf
  8. Guidet B, Nicola I, Barakett V, Gabillet JM, Snoey E et al. Skin versus hub cultures to predict colonization and infection of central venous catheter in intensive care patients. Infection 1994; 22:43–48 [View Article] [PubMed]
     [Google Scholar]
  9. Maki DG, Martin WT. Nationwide epidemic of septicemia caused by contaminated infusion products. IV. Growth of microbial pathogens in fluids for intravenous infusions. J Infect Dis 1975; 131:267–272 [View Article] [PubMed]
     [Google Scholar]
  10. Salzman MB, Isenberg HD, Shapiro JF, Lipsitz PJ, Rubin LG et al. A prospective study of the catheter hub as the portal of entry for microorganisms causing catheter-related sepsis in neonates. J Infect Dis 1993; 167:487–490 [View Article] [PubMed]
     [Google Scholar]
  11. Tassinari M, Zannoli S, Farabegoli P, Pedna MF, Pierro A et al. Rapid diagnosis of bloodstream infections in the critically ill: Evaluation of the broad-range PCR/ESI-MS technology. PLoS One 2018; 13:e0197436 [View Article] [PubMed]
     [Google Scholar]
  12. Lamy B, Dargère S, Arendrup MC, Parienti J-J, Tattevin P et al. How to optimize the use of blood cultures for the diagnosis of bloodstream infections? a state-of-the art. Front Microbiol 2016; 7:697 [View Article] [PubMed]
     [Google Scholar]
  13. Haddadin Y, Annamaraju P, Regunath H. Central Line Associated Blood Stream Infections. In StatPearls Treasure Island (FL): StatPearls Publishing; 2021
     [Google Scholar]
  14. Pronovost P, Needham D, Berenholtz S, Sinopoli D, Chu H et al. An intervention to decrease catheter-related bloodstream infections in the ICU. N Engl J Med 2006; 355:2725–2732 [View Article] [PubMed]
     [Google Scholar]
  15. Alby-Laurent F, Lambe C, Ferroni A, Salvi N, Lebeaux D et al. Salvage strategy for long-term central venous catheter-associated Staphylococcus aureus infections in children. Front Pediatr 2018; 6:427 [View Article] [PubMed]
     [Google Scholar]
  16. Mermel LA, Farr BM, Sherertz RJ, Raad II, O’Grady N et al. Guidelines for the management of intravascular catheter-related infections. Clin Infect Dis 2001; 32:1249–1272 [View Article] [PubMed]
     [Google Scholar]
  17. Messing B, Peitra-Cohen S, Debure A, Beliah M, Bernier JJ et al. Antibiotic-lock technique: a new approach to optimal therapy for catheter-related sepsis in home-parenteral nutrition patients. JPEN J Parenter Enteral Nutr 1988; 12:185–189 [View Article] [PubMed]
     [Google Scholar]
  18. Gaillard JL, Merlino R, Pajot N, Goulet O, Fauchere JL et al. Conventional and nonconventional modes of vancomycin administration to decontaminate the internal surface of catheters colonized with coagulase-negative staphylococci. JPEN J Parenter Enteral Nutr 1990; 14:593–597 [View Article] [PubMed]
     [Google Scholar]
  19. See I, Freifeld AG, Magill SS. Causative organisms and associated antimicrobial resistance in healthcare-associated, central line-associated bloodstream infections from oncology settings, 2009-2012. Clin Infect Dis 2016; 62:1203–1209 [View Article] [PubMed]
     [Google Scholar]
  20. Vila A, Jahan C, Rivero C, Amadio C, Ampuero A et al. Central line associated blood stream infection (CLABSI) due to Exophiala dermatitidis in an adult patient: Case report and review. Med Mycol Case Rep 2019; 24:33–36 [View Article] [PubMed]
     [Google Scholar]
  21. Campos-Herrero MI, García D, Figuerola A, Suárez P, Campo C et al. Bacteremia caused by the novel species Mycobacterium canariasense. Eur J Clin Microbiol Infect Dis 2006; 25:58–60 [View Article] [PubMed]
     [Google Scholar]
  22. Kantarcioglu AS, de Hoog GS. Infections of the central nervous system by melanized fungi: a review of cases presented between 1999 and 2004. Mycoses 2004; 47:4–13 [View Article] [PubMed]
     [Google Scholar]
  23. Sudhadham M, Prakitsin S, Sivichai S, Chaiyarat R, Dorrestein GM et al. The neurotropic black yeast Exophiala dermatitidis has a possible origin in the tropical rain forest. Stud Mycol 2008; 61:145–155 [View Article] [PubMed]
     [Google Scholar]
  24. Matos T, de Hoog GS, de Boer AG, de Crom I, Haase G et al. High prevalence of the neurotrope Exophiala dermatitidis and related oligotrophic black yeasts in sauna facilities. Mycoses 2002; 45:373–377 [View Article] [PubMed]
     [Google Scholar]
  25. Chen M, Zhang J, Dong Z, Wang F et al. Cutaneous phaeohyphomycosis caused by Exophiala dermatitidis: A case report and literature review. Indian J Dermatol Venereol Leprol 2016; 82:173–177 [View Article] [PubMed]
     [Google Scholar]
  26. Wheeler MH, Abramczyk D, Puckhaber LS, Naruse M, Ebizuka Y et al. New biosynthetic step in the melanin pathway of Wangiella (Exophiala) dermatitidis: evidence for 2-acetyl-1,3,6,8-Tetrahydroxynaphthalene as a novel precursor. Eukaryot Cell 2008; 7:1699–1711 [View Article] [PubMed]
     [Google Scholar]
  27. Schnitzler N, Peltroche-Llacsahuanga H, Bestier N, Zündorf J, Lütticken R et al. Effect of melanin and carotenoids of Exophiala (Wangiella) dermatitidis on phagocytosis, oxidative burst, and killing by human neutrophils. Infect Immun 1999; 67:94–101 [View Article] [PubMed]
     [Google Scholar]
  28. Vasquez A, Zavasky D, Chow NA, Gade L, Zlatanic E et al. Management of an outbreak of Exophiala dermatitidis bloodstream infections at an outpatient oncology clinic. Clin Infect Dis 2018; 66:959–962 [View Article] [PubMed]
     [Google Scholar]
  29. Kirchhoff L, Olsowski M, Rath P-M, Steinmann J et al. Exophiala dermatitidis: Key issues of an opportunistic fungal pathogen. Virulence 2019; 10:984–998 [View Article] [PubMed]
     [Google Scholar]
  30. Wang C, Xing H, Jiang X, Zeng J, Liu Z et al. Cerebral phaeohyphomycosis caused by Exophiala dermatitidis in A Chinese CARD9-deficient patient: a case report and literature review. Front Neurol 2019; 10:938 [View Article] [PubMed]
     [Google Scholar]
  31. Matsumoto T, Matsuda T, McGinnis MR, Ajello L et al. Clinical and mycological spectra of Wangiella dermatitidis infections. Mycoses 1993; 36:145–155 [View Article] [PubMed]
     [Google Scholar]
  32. Prenafeta-Boldú FX, Summerbell R, Sybren de Hoog G. Fungi growing on aromatic hydrocarbons: biotechnology’s unexpected encounter with biohazard?. FEMS Microbiol Rev 2006; 30:109–130 [View Article] [PubMed]
     [Google Scholar]
  33. Song Y, Laureijssen-van de Sande WWJ, Moreno LF, Gerrits van den Ende B, Li R et al. Comparative ecology of capsular exophiala species causing disseminated infection in humans. Front Microbiol 2017; 8:2514 [View Article] [PubMed]
     [Google Scholar]
  34. Grenouillet F, Cimon B, Pana-Katatali H, Person C, Gainet-Brun M et al. Exophiala dermatitidis revealing cystic fibrosis in adult patients with chronic pulmonary disease. Mycopathologia 2018; 183:71–79 [View Article] [PubMed]
     [Google Scholar]
  35. De Hoog GS, Queiroz-Telles F, Haase G, Fernandez-Zeppenfeldt G, Attili Angelis D et al. Black fungi: clinical and pathogenic approaches. Med Mycol 2000; 38 Suppl 1:243–250 [PubMed]
     [Google Scholar]
  36. Zacharioudakis IM, Zervou FN, Mylonakis E. T2 magnetic resonance assay: overview of available data and clinical implications. J Fungi (Basel) 2018; 4:45 [View Article] [PubMed]
     [Google Scholar]
  37. Lang R, Minion J, Skinner S, Wong A et al. Disseminated Exophiala dermatitidis causing septic arthritis and osteomyelitis. BMC Infect Dis 2018; 18:255 [View Article] [PubMed]
     [Google Scholar]
  38. Scott LJ, Simpson D. Voriconazole. Drugs 2007; 67:269–298 [View Article] [PubMed]
     [Google Scholar]
  39. Boyd AE, Modi S, Howard SJ, Moore CB, Keevil BG et al. Adverse reactions to voriconazole. Clin Infect Dis 2004; 39:1241–1244 [View Article] [PubMed]
     [Google Scholar]
  40. CDC Nontuberculous Mycobacteria (NTM) Infections; 2022. [accessed May 2021] https://www.cdc.gov/hai/organisms/nontuberculous-mycobacteria.html
  41. Jiménez MS, Campos-Herrero MI, García D, Luquin M, Herrera L et al. Mycobacterium canariasense sp. nov. Int J Syst Evol Microbiol 2004; 54:1729–1734 [View Article] [PubMed]
     [Google Scholar]
  42. Azadi D, Dibaj R, Pourchangiz M, Daei-Naser A, Shojaei H et al. First report of isolation of Mycobacterium canariasense from hospital water supplies. Scand J Infect Dis 2014; 46:792–796 [View Article] [PubMed]
     [Google Scholar]
  43. Springer B, Böttger EC, Kirschner P, Wallace RJ Jr et al. Phylogeny of the Mycobacterium chelonae-like organism based on partial sequencing of the 16S rRNA gene and proposal of Mycobacterium mucogenicum sp. nov. Int J Syst Bacteriol 1995; 45:262–267 [View Article] [PubMed]
     [Google Scholar]
  44. Schröder KH, Naumann L, Kroppenstedt RM, Reischl U et al. Mycobacterium hassiacum sp. nov., a new rapidly growing thermophilic mycobacterium. Int J Syst Bacteriol 1997; 47:86–91 [View Article] [PubMed]
     [Google Scholar]
  45. Jang M-A, Koh W-J, Huh HJ, Kim S-Y, Jeon K et al. Distribution of nontuberculous mycobacteria by multigene sequence-based typing and clinical significance of isolated strains. J Clin Microbiol 2014; 52:1207–1212 [View Article] [PubMed]
     [Google Scholar]
  46. Kim H, Kim S-H, Shim T-S, Kim M-N, Bai G-H et al. Differentiation of Mycobacterium species by analysis of the heat-shock protein 65 gene (hsp65). Int J Syst Evol Microbiol 2005; 55:1649–1656 [View Article] [PubMed]
     [Google Scholar]
  47. Turenne CY, Tschetter L, Wolfe J, Kabani A et al. Necessity of quality-controlled 16S rRNA gene sequence databases: identifying nontuberculous Mycobacterium species. J Clin Microbiol 2001; 39:3637–3648 [View Article] [PubMed]
     [Google Scholar]
  48. Paniz-Mondolfi A, Ladutko L, Brown-Elliott BA, Vasireddy R, Vasireddy S et al. First report of Mycobacterium canariasense catheter-related bacteremia in the Americas. J Clin Microbiol 2014; 52:2265–2269 [View Article] [PubMed]
     [Google Scholar]
http://instance.metastore.ingenta.com/content/journal/acmi/10.1099/acmi.0.000347
Loading
Case report and literature review: double jeopardy – Exophiala dermatitidis and Mycobacterium canariasense central line-associated bloodstream infection in a patient
Access Microbiology 4, 000347 (2022); https://doi.org/10.1099/acmi.0.000347
/content/journal/acmi/10.1099/acmi.0.000347
/content/journal/acmi/10.1099/acmi.0.000347
Loading

Data & Media loading...

Most cited Most Cited RSS feed

This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error